Literature DB >> 8898999

Prostate cancer, race, and socioeconomic status: inadequate adjustment for social factors in assessing racial differences.

W Dale1, S Vijayakumar, E F Lawlor, K Merrell.   

Abstract

BACKGROUND: This paper reviews the state of the art in analyzing race, social factors, and economic factors in cancer research, with an emphasis on prostate cancer and the role of socioeconomic status (SES) in racial differences in mortality. It analyzes the quality of articles in the literature that assess the role of SES in cancer mortality.
METHODS: English-language titles were identified using MEDLINE with publication dates from mid-1985 through July 1994. Articles in the references of these articles were also included in the final selection, based originally on title and ultimately on content, dating back to 1978. Articles that included SES information and distinguished between whites and African-Americans were chosen, resulting in a final selection of 21 articles. Articles are summarized with consideration of five criteria considered minimal requirements of a well-designed study of the role of race in cancer mortality: (1) SES measure(s) should be on an individual level, not census level; (2) SES should be controlled for when making comparisons between whites and blacks; (3) SES should include at least (individual level) measures of income and education; (4) sample sizes are sufficient for the relevant populations; and (5) specific cancer sites should be studied separately.
RESULTS: Of the articles reviewed, only two meet the minimum standards, neither of which studied prostate cancer. It is not clear whether observed racial differences in prostate cancer are directly attributable to race or reflect underlying social factor differences between whites and African-Americans.
CONCLUSIONS: In the future, specific characteristics of SES should be measured at the individual level; there is a need for expansion and standardization of data in terms of social and economic content; other methodological advances are needed in modeling to take into consideration the influence of SES in outcome research related to cancer.

Entities:  

Mesh:

Year:  1996        PMID: 8898999     DOI: 10.1002/(SICI)1097-0045(199611)29:5<271::AID-PROS1>3.0.CO;2-D

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  7 in total

Review 1.  Is race an independent prognostic factor for survival from prostate cancer?

Authors:  M Roach
Journal:  J Natl Med Assoc       Date:  1998-11       Impact factor: 1.798

Review 2.  Risk-based prostate cancer screening: who and how?

Authors:  Allison S Glass; K Clint Cary; Matthew R Cooperberg
Journal:  Curr Urol Rep       Date:  2013-06       Impact factor: 3.092

3.  An exploration of the complex relationship of socioecologic factors in the treatment and outcomes of acute myocardial infarction in disadvantaged populations.

Authors:  J J Shen; T T Wan; J B Perlin
Journal:  Health Serv Res       Date:  2001-08       Impact factor: 3.402

4.  Effect of socioeconomic status as measured by education level on survival in breast cancer clinical trials.

Authors:  James E Herndon; Alice B Kornblith; Jimmie C Holland; Electra D Paskett
Journal:  Psychooncology       Date:  2011-10-20       Impact factor: 3.894

5.  Patient education level as a predictor of survival in lung cancer clinical trials.

Authors:  James E Herndon; Alice B Kornblith; Jimmie C Holland; Electra D Paskett
Journal:  J Clin Oncol       Date:  2008-09-01       Impact factor: 44.544

6.  Effect of socioeconomic factors on long-term mortality in men with clinically localized prostate cancer.

Authors:  Ashutosh K Tewari; Heather Taffet Gold; Raymond Y Demers; Christine Cole Johnson; Rajiv Yadav; Edward H Wagner; Marianne Ulcickas Yood; Terri S Field; George Divine; Mani Menon
Journal:  Urology       Date:  2009-01-23       Impact factor: 2.649

7.  Health Burdens and SES in Alabama: Using Geographic Information System to Examine Prostate Cancer Health Disparity.

Authors:  Seela Aladuwaka; Ram Alagan; Rajesh Singh; Manoj Mishra
Journal:  Cancers (Basel)       Date:  2022-10-02       Impact factor: 6.575

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.